USPTO 2015–2025 USPTO PatentsView US Corporation

Lyten, Inc.

USPTO PatentsView assignee record - 154 granted patents across 77 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c).

RSS updates for this company

The verdict

According to USPTO PatentsView, Lyten ranks #2,528 of 49,997 tracked US assignees by granted-patent volume, with 154 patents across 77 technology areas.

#2,528
of 49,997 US assignees by volume
Top 1%
by Innovation Score (70.7/100)
20.5
avg claims per patent
+535%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2528 · US Corporation #2,528 · 154 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 154 grants
  • TOP-DECILE #2,528/49,997
  • PHOTO-FINISH Cancer Research…
  • CPC-WIDE C01B · 77 areas
  • INNOV-STRONG 70.7/100
  • CLAIMS-DENSE 20.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +535% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cancer Research Technology Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Lyten

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Lyten's Innovation Score is 70.7/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Lyten's grant cadence moved

Between 2020–2024, Lyten, Inc. received 108 grants versus 17 in 2015–2019 (+535% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2024 at 32 grants and bottomed in 2017 at 2. Lead class C01B accounts for 35.7% of the portfolio across 77 subclasses. Volume neighbours: Cancer Research Technology Limited (#2,523) and Polestar Performance AB (#2,531).

Lyten's three-year grant acceleration

From 2019–2021 to 2022–2024, Lyten, Inc. moved from 35 to 84 grants (2.40x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #131. See the growth leaderboard.

Who files at Lyten's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Lyten holds 154 patents at rank #2,527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Lyten

By rank, the assignees closest to #2,527 in granted patent volume.

Leaders in C01B (Non-metallic Elements)

Other assignees with the most granted patents in Lyten's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lyten, neither rank-band nor same-CPC leaders (those blocks stay above).

Lyten's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

71 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 201720182019202020212022202320242025 29
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Lyten, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 1.3%
2018 4 2.6%
2019 11 7.1%
2020 9 5.8%
2021 15 9.7%
2022 21 13.6%
2023 31 20.1%
2024 32 20.8%
2025partial year 29 18.8%

Which technologies does Lyten, Inc. patent most?

Top 15 of 77 technology areas

Where it ranks

Overall rank by patents

#2,528

of 49,997 tracked assignees

Innovation Score

70.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Lyten, Inc.'s patent record in context - here's where to go next.

  • Lyten, Inc.'s lead technology class is C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c), 35.7% of its portfolio - see every assignee active in that class. Explore C01B
  • Ranked #2,528 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Lyten, Inc. against Cancer Research Technology Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 70.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.